factual

Delivery reduces to getting nucleic acids into any cell type

The delivery problem for genetic medicines can be reduced to getting nucleic acids into any desired cell type specifically, since nucleic acids can drug anything in the genome; current modalities are lipid nanoparticles (fat bubbles defaulting to liver, tunable via attached antibodies) and viral vectors like AAV (limited packaging size), and sequence engineering can only add NOT gates to narrow delivery, never expand it to cells not initially reached.

factualpending

Speaker

Jacob Kimmel

Evidence Quote

“You can start broad with your delivery vector and then use sequence to narrow down to make it more specific, but not the other way around.”

Source

Evolution designed us to die fast; we can change that — Jacob Kimmel— Dwarkesh Patel Podcast
Created: 6/13/2026, 3:28:32 AM

Your notes

Loading notes...